Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Unknown 4Completed 3Suspended 1Recruiting 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4

Conditions

Stomach Neoplasms 32Carcinoma, Hepatocellular 22Carcinoma, Non-Small-Cell Lung 16Small Cell Lung Carcinoma 11Ovarian Neoplasms 11Colorectal Neoplasms 11Sarcoma 9Lung Neoplasms 9Nasopharyngeal Carcinoma 7Neoplasms 6Breast Neoplasms 6Triple Negative Breast Neoplasms 5Head and Neck Neoplasms 5Glioma 5Esophageal Neoplasms 5Cholangiocarcinoma 5Recurrence 4Pancreatic Neoplasms 4Osteosarcoma 4Esophageal Squamous Cell Carcinoma 4Biliary Tract Neoplasms 4Advanced Gastric Cancer 4Uterine Cervical Neoplasms 3Thyroid Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Solid Tumor 3Neoplasm Metastasis 3NSCLC 3Melanoma 3Gastrointestinal Neoplasms 3

Interventions

Methotrexate 5Drug Therapy 5apatinib 4Neoadjuvant Therapy 4Doxorubicin 3camrelizumab 2Ifosfamide 2Cisplatin 2trilaciclib 1spartalizumab 1palbociclib 1isophosphamide mustard 1irinotecan sucrosofate 1glucarpidase 1endostar protein 1Zoledronic Acid 1Vinorelbine 1Triptorelin Pamoate 1Trabectedin 1Therapeutics 1Thalidomide 1TQ-B3525 1Psychiatric Rehabilitation 1Nivolumab 1Neuropsychological Tests 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1Microbiota 1Metabolome 1Magnetic Resonance Spectroscopy 1Lithium Carbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Osteosarcoma × apatinib × Clear all
NCT06125171 2023-11-09

Tucidinostat Plus Apatinib for Advanced Osteosarcoma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 2 Unknown
46 enrolled
Sarcoma

Osteosarcoma

NCT03742193 2023-11-01

PROACH

Ruijin Hospital

Phase 2 Unknown
43 enrolled
Sarcoma

Osteosarcoma

NCT04351308 2020-05-19

MAPAC

Peking University People's Hospital

Phase 2 Unknown
60 enrolled
Sarcoma

Osteosarcoma, Drug-Related Side Effects and Adverse Reactions

NCT03163381 2017-05-23

Apatinib Second Line Treatment for Advanced Osteosarcoma and Soft Tissue Sarcomas ,Openting ,Single Center, One-armed Clinical Study.

Henan Cancer Hospital

Phase 2 Unknown
40 enrolled
Sarcoma

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡